Production (Stage)
STAAR Surgical Company
STAA
$18.68
-$0.09-0.48%
NASDAQ
| 03/28/2025 | 12/27/2024 | 09/27/2024 | 06/28/2024 | 03/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -71.08M | -20.21M | 21.78M | 16.61M | 15.30M |
| Total Depreciation and Amortization | 7.99M | 6.89M | 5.73M | 5.31M | 5.24M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 44.22M | 34.44M | 30.08M | 29.46M | 30.56M |
| Change in Net Operating Assets | 7.18M | -5.40M | -10.53M | -14.12M | -9.73M |
| Cash from Operations | -11.69M | 15.73M | 47.05M | 37.26M | 41.37M |
| Capital Expenditure | -19.66M | -23.39M | -20.76M | -23.71M | -20.49M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -20.39M | -35.82M | 3.44M | 73.47M | 101.09M |
| Cash from Investing | -40.05M | -59.22M | -17.32M | 49.76M | 80.60M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -167.00K | -165.00K | -164.00K | -161.00K | -159.00K |
| Issuance of Common Stock | 2.45M | 7.39M | 7.76M | 13.36M | 14.47M |
| Repurchase of Common Stock | -1.56M | -1.51M | -1.40M | -1.51M | -1.48M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 720.00K | 5.72M | 6.20M | 11.69M | 12.83M |
| Foreign Exchange rate Adjustments | 112.00K | -1.11M | 638.00K | -634.00K | -745.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50.91M | -38.88M | 36.57M | 98.08M | 134.06M |